EBS News and Press, Emergent Biosolutions Inc. From 11/23/21

A couple of retailers saw their stocks plummet in Tuesday's pre-market action despite quarterly earnings that nominally beat expectations. Best Buy (NYSE:BBY) and Urban Outfitters (NASDAQ:URBN) posted double-digit percentage declines on signs that sales won't be able to keep up their recent b...

SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 PR Newswire NEW YORK , Nov. 22, 2021 /PRNewswire/ -- SiTime Corp. (NASD: S...

Emergent BioSolutions (NYSE:EBS) will leave the S&P MidCap 400 and join the S&P SmallCap 600, prior to the beginning of trading on Nov. 30. Emergent shares are down 55% year-to-date, as the company has been hurt by vaccine manufacturing issues at its Baltimore plant. Earlier...

The modification/loss of a contract coupled with a weak earnings report sent the stock tumbling 40%. We jumped on this overreaction for a quick gain, but now see the stock rallying further into 2022 on some bullish developments. The company is anticipating a significant top-line r...

It's always pleasant when one of our stocks pays us rather than the other way around. Such is the case with vaccine and antibody company Emergent BioSolutions (NYSE: EBS) , which closed Friday more than 4% higher after it announced it would open its wallet to buy shares of its own e...

Emergent BioSolutions (NYSE:EBS) is trading ~4.4% higher after the company announced an authorization to repurchase up to $250M of the company’s common stock. Based on market conditions and other factors, the buybacks will be carried out from time to time on the open mar...

GAITHERSBURG, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized management to repurchase up to $250 million of the company's common stock from time to time on the open market or in privatel...

After securing its first EUA from the Republic of Indonesia, Novavax is poised to receive a string of use authorizations from a variety of centers around the globe. The company has lined up myriad fill/finish facilities across the globe and authorized exclusive licensing agreements wi...

The FDA has greenlighted two additional COVID-19 vaccine batches manufactured by Emergent Biosolutions (NYSE:EBS) for Johnson & Johnson (NYSE:JNJ). The regulator has determined that the batches were safe for use following a thorough review and considering the requirements during...

Earnings news remained the crucial driver during Friday's midday action. Airbnb (NASDAQ:ABNB), Pinterest (NYSE:PINS) and Uber (NYSE:UBER) all showed notable gains following the release of their quarterly reports. Elsewhere, Emergent (NYSE:EBS) lost about two-fifths of its value after disclosi...